MELANIE BANAL: Open Payments
NPI 1770986010 · BREESE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 41 payments from 15 companies in 2025. Trend: 2023 $563 · 2024 $45 · 2025 $864
Food & beverage: $805Education: $60
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $240 |
| GENZYME CORPORATION | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Philips North America LLC | 3 | $62 |
| SANOFI-AVENTIS U.S. LLC | 1 | $60 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $32 |
| Verona Pharma, Inc. | 2 | $31 |
| Grifols USA, LLC | 1 | $22 |
| Electromed, Inc. | 2 | $20 |
Products named: DUPIXENT, MOUNJARO, Encore, BREZTRI, TEZSPIRE, Rybelsus, Ohtuvayre, Prolastin-C Liquid.
Industry payments across IL — which companies pay providers there.
